Home » Topics » Infection » HIV/AIDS

HIV/AIDS
RSS

ZY-1 demonstrates therapeutic promise in HIV patients

July 26, 1996

TAR-PAK-140: University of Alberta's anti-HIV vector

July 26, 1996

Mulsal N shows significant CD4 cell count increases in trial

July 26, 1996

Virulizin enters phase I/II for drug-resistant HIV-related Kaposi's sarcoma

July 26, 1996

Columbia Laboratories' SPC3 undergoes phase I/II trials

July 26, 1996

Allophenylnorstatine HIV protease inhibitors described

July 26, 1996

Sequus licenses liposome-CD4 technology

July 26, 1996

Gilead Science's sulfone HIV protease inhibitors

July 26, 1996

Positive phase I/II results for PDT's SnET2 in AIDS-associated Kaposi's sarcoma patients

July 19, 1996

Interim results from ALRT-1057 phase I/II trials

July 19, 1996

Popular Stories

News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...